Page 107 - Read Online

Page 16 of 18 Alqahtani et al. Hepatoma Res 2020;6:58 I http://dx.doi.org/10.20517/2394-5079.2020.49

94. Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Serag HB. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular
cancer in a national sample of U.S. Veterans with HCV. Hepatology 2014;60:98-105.
95. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma
development: a meta-analysis. J Hepatol 2009;50:1142-54.
96. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
97. Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin
Gastroenterol Hepatol 2005;3:1150-9.
98. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and
hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323-31.
99. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, et al; Brescia HCC Study. Case-control study on hepatitis C virus (HCV) as a
risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Int J Cancer
1999;81:695-9.
100. Monto A, Patel K, Bostrom A, Pianko S, Pockros P, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology
2004;39:826-34.
101. Vandenbulcke H, Moreno C, Colle I, Knebel JF, Francque S, et al. Alcohol intake increases the risk of HCC in hepatitis C virus-related
compensated cirrhosis: a prospective study. J Hepatol 2016;65:543-51.
102. Dyal HK, Aguilar M, Bartos G, Holt EW, Bhuket T, et al. Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis
C virus patients: a systematic review. Dig Dis Sci 2016;61:636-45.
103. Huang TS, Lin CL, Lu MJ, Yeh CT, Liang KH, et al. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: a
population-based cohort study. J Gastroenterol Hepatol 2017;32:1355-62.
104. Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, et al. NAFLD and NASH in HCV infection: prevalence and significance in
hepatic and extrahepatic manifestations. Int J Mol Sci 2016;17:803.
105. Castéra L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani ES, et al. Worsening of steatosis is an independent factor of fibrosis
progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003;52:288-92.
106. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes
mellitus, and alcohol. Hepatology 2002;36:729-36.
107. Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM. The impact of hepatic steatosis on the natural history of chronic hepatitis C
infection. J Viral Hepat 2009;16:492-9.
108. Lonardo A, Adinolfi LE, Restivo L, Ballestri S, Romagnoli D, et al. Pathogenesis and significance of hepatitis C virus steatosis: an update
on survival strategy of a successful pathogen. World J Gastroenterol 2014;20:7089-103.
109. Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive
histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol 2010;34:1630-6.
110. Tanaka A, Uegaki S, Kurihara H, Aida K, Mikami M, et al. Hepatic steatosis as a possible risk factor for the development of
hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World J
Gastroenterol 2007;13:5180-7.
111. Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in
patients with hepatitis C-related cirrhosis. Cancer 2007;109:2490-6.
112. Kumar D, Farrell GC, Kench J, George J. Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C. J Gastroenterol
Hepatol 2005;20:1395-400.
113. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients
with chronic hepatitis C virus infection. Cancer 2003;97:3036-43.
114. Rao H, Wu E, Fu S, Yang M, Feng B, et al. The higher prevalence of truncal obesity and diabetes in American than Chinese patients with
chronic hepatitis C might contribute to more rapid progression to advanced liver disease. Aliment Pharmacol Ther 2017;46:731-40.
115. Singal AG, Mukherjee A, Elmunzer BJ, Higgins PD, Lok AS, et al. Machine learning algorithms outperform conventional regression
models in predicting development of hepatocellular carcinoma. Am J Gastroenterol 2013;108:1723-30.
116. El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P. A new laboratory-based algorithm to predict development of hepatocellular
carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology 2014;146:1249-55.e1.
117. Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, et al. Risk factors for development of hepatocellular carcinoma in patients with chronic
hepatitis C after sustained response to interferon. J Gastroenterol 2005;40:148-56.
118. Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular
carcinoma. J Hepatol 2014;61:S79-90.
119. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
120. Aroucha DC, do Carmo RF, Moura P, Silva JL, Vasconcelos LR, et al. High tumor necrosis factor-α/interleukin-10 ratio is associated with
hepatocellular carcinoma in patients with chronic hepatitis C. Cytokine 2013;62:421-5.
121. Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, et al. Hepatitis C virus proteins modulate microRNA expression and
chemosensitivity in malignant hepatocytes. Clin Cancer Res 2010;16:957-66.
122. Zhang Y, Wei W, Cheng N, Wang K, Li B, et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes
hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012;56:1631-40.
123. Hou W, Bonkovsky HL. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early
detection, diagnosis and therapy. World J Gastroenterol 2013;19:7836-45.